nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.071	0.282	CbGbCtD
Zaleplon—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.048	0.19	CbGbCtD
Zaleplon—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0458	0.182	CbGbCtD
Zaleplon—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0408	0.162	CbGbCtD
Zaleplon—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0239	0.095	CbGbCtD
Zaleplon—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0226	0.0897	CbGbCtD
Zaleplon—AOX1—Effects of Nitric Oxide—NOS2—chronic obstructive pulmonary disease	0.00463	0.0467	CbGpPWpGaD
Zaleplon—AOX1—Effects of Nitric Oxide—NOS3—chronic obstructive pulmonary disease	0.00372	0.0376	CbGpPWpGaD
Zaleplon—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00361	0.0364	CbGpPWpGaD
Zaleplon—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00319	0.0322	CbGpPWpGaD
Zaleplon—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00261	0.0263	CbGpPWpGaD
Zaleplon—AOX1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00194	0.0196	CbGpPWpGaD
Zaleplon—GABRB2—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00182	0.0184	CbGpPWpGaD
Zaleplon—GABRA2—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00171	0.0172	CbGpPWpGaD
Zaleplon—CYP3A7—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.0017	0.0172	CbGpPWpGaD
Zaleplon—GABRB3—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00169	0.0171	CbGpPWpGaD
Zaleplon—GABRG2—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00166	0.0168	CbGpPWpGaD
Zaleplon—GABRB2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00162	0.0164	CbGpPWpGaD
Zaleplon—GABRA2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00152	0.0153	CbGpPWpGaD
Zaleplon—GABRB3—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00151	0.0152	CbGpPWpGaD
Zaleplon—GABRG2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00148	0.015	CbGpPWpGaD
Zaleplon—GABRA1—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00145	0.0147	CbGpPWpGaD
Zaleplon—AOX1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00141	0.0143	CbGpPWpGaD
Zaleplon—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00132	0.0134	CbGpPWpGaD
Zaleplon—GABRA1—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.0013	0.0131	CbGpPWpGaD
Zaleplon—CYP3A5—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.00128	0.0129	CbGpPWpGaD
Zaleplon—CYP3A7—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00124	0.0125	CbGpPWpGaD
Zaleplon—CYP3A5—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00123	0.0124	CbGpPWpGaD
Zaleplon—CYP3A5—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00118	0.0119	CbGpPWpGaD
Zaleplon—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.00101	0.0102	CbGpPWpGaD
Zaleplon—CYP3A5—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000893	0.00901	CbGpPWpGaD
Zaleplon—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00089	0.00898	CbGpPWpGaD
Zaleplon—CYP3A5—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000859	0.00867	CbGpPWpGaD
Zaleplon—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000834	0.00842	CbGpPWpGaD
Zaleplon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000829	0.00837	CbGpPWpGaD
Zaleplon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000814	0.00821	CbGpPWpGaD
Zaleplon—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000787	0.00794	CbGpPWpGaD
Zaleplon—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000726	0.00732	CbGpPWpGaD
Zaleplon—CYP3A7—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000722	0.00729	CbGpPWpGaD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000712	0.00718	CbGpPWpGaD
Zaleplon—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000706	0.00713	CbGpPWpGaD
Zaleplon—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.0007	0.00108	CcSEcCtD
Zaleplon—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.0007	0.00108	CcSEcCtD
Zaleplon—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.0007	0.00108	CcSEcCtD
Zaleplon—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.0007	0.00108	CcSEcCtD
Zaleplon—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000698	0.00108	CcSEcCtD
Zaleplon—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000698	0.00108	CcSEcCtD
Zaleplon—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000698	0.00108	CcSEcCtD
Zaleplon—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000697	0.00107	CcSEcCtD
Zaleplon—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000697	0.00107	CcSEcCtD
Zaleplon—CYP3A7—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000697	0.00703	CbGpPWpGaD
Zaleplon—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000696	0.00107	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000695	0.00107	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000695	0.00107	CcSEcCtD
Zaleplon—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.000695	0.00107	CcSEcCtD
Zaleplon—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000692	0.00107	CcSEcCtD
Zaleplon—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000692	0.00107	CcSEcCtD
Zaleplon—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000686	0.00106	CcSEcCtD
Zaleplon—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000686	0.00106	CcSEcCtD
Zaleplon—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000686	0.00106	CcSEcCtD
Zaleplon—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000685	0.00106	CcSEcCtD
Zaleplon—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000685	0.00106	CcSEcCtD
Zaleplon—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000683	0.00105	CcSEcCtD
Zaleplon—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000683	0.00689	CbGpPWpGaD
Zaleplon—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000683	0.00105	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000681	0.00105	CcSEcCtD
Zaleplon—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00068	0.00686	CbGpPWpGaD
Zaleplon—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00068	0.00105	CcSEcCtD
Zaleplon—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000678	0.00104	CcSEcCtD
Zaleplon—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000677	0.00104	CcSEcCtD
Zaleplon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000676	0.00682	CbGpPWpGaD
Zaleplon—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000671	0.00103	CcSEcCtD
Zaleplon—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000671	0.00103	CcSEcCtD
Zaleplon—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000671	0.00103	CcSEcCtD
Zaleplon—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000671	0.00103	CcSEcCtD
Zaleplon—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00067	0.00103	CcSEcCtD
Zaleplon—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000669	0.00103	CcSEcCtD
Zaleplon—GABRB2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000669	0.00675	CbGpPWpGaD
Zaleplon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000664	0.0067	CbGpPWpGaD
Zaleplon—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000661	0.00102	CcSEcCtD
Zaleplon—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000661	0.00102	CcSEcCtD
Zaleplon—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000661	0.00102	CcSEcCtD
Zaleplon—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000661	0.00102	CcSEcCtD
Zaleplon—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000659	0.00102	CcSEcCtD
Zaleplon—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000658	0.00101	CcSEcCtD
Zaleplon—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000658	0.00101	CcSEcCtD
Zaleplon—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000657	0.00101	CcSEcCtD
Zaleplon—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000657	0.00101	CcSEcCtD
Zaleplon—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000657	0.00101	CcSEcCtD
Zaleplon—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000655	0.00101	CcSEcCtD
Zaleplon—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000655	0.00101	CcSEcCtD
Zaleplon—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000653	0.00101	CcSEcCtD
Zaleplon—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000652	0.00101	CcSEcCtD
Zaleplon—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000652	0.001	CcSEcCtD
Zaleplon—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000652	0.001	CcSEcCtD
Zaleplon—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000647	0.000997	CcSEcCtD
Zaleplon—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000646	0.000995	CcSEcCtD
Zaleplon—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000645	0.000994	CcSEcCtD
Zaleplon—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000639	0.000984	CcSEcCtD
Zaleplon—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000636	0.00098	CcSEcCtD
Zaleplon—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000634	0.000977	CcSEcCtD
Zaleplon—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000634	0.000977	CcSEcCtD
Zaleplon—GABRB2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000633	0.00639	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000627	0.00633	CbGpPWpGaD
Zaleplon—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000627	0.000967	CcSEcCtD
Zaleplon—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000627	0.000967	CcSEcCtD
Zaleplon—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000624	0.000962	CcSEcCtD
Zaleplon—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000624	0.000961	CcSEcCtD
Zaleplon—GABRB3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000623	0.00629	CbGpPWpGaD
Zaleplon—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000622	0.00627	CbGpPWpGaD
Zaleplon—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000622	0.000958	CcSEcCtD
Zaleplon—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000621	0.000957	CcSEcCtD
Zaleplon—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000619	0.000953	CcSEcCtD
Zaleplon—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000618	0.000952	CcSEcCtD
Zaleplon—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000616	0.000949	CcSEcCtD
Zaleplon—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000613	0.000944	CcSEcCtD
Zaleplon—GABRG2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000612	0.00618	CbGpPWpGaD
Zaleplon—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000612	0.000942	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000612	0.000942	CcSEcCtD
Zaleplon—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000607	0.000936	CcSEcCtD
Zaleplon—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000607	0.000936	CcSEcCtD
Zaleplon—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000604	0.000931	CcSEcCtD
Zaleplon—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000601	0.000926	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000599	0.000923	CcSEcCtD
Zaleplon—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000598	0.000922	CcSEcCtD
Zaleplon—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000598	0.000922	CcSEcCtD
Zaleplon—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000597	0.00092	CcSEcCtD
Zaleplon—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000597	0.00092	CcSEcCtD
Zaleplon—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000595	0.00601	CbGpPWpGaD
Zaleplon—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000595	0.000916	CcSEcCtD
Zaleplon—GABRA2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000594	0.00599	CbGpPWpGaD
Zaleplon—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000592	0.000913	CcSEcCtD
Zaleplon—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000591	0.000911	CcSEcCtD
Zaleplon—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000591	0.000911	CcSEcCtD
Zaleplon—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00059	0.00091	CcSEcCtD
Zaleplon—GABRB3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00059	0.00595	CbGpPWpGaD
Zaleplon—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000588	0.000907	CcSEcCtD
Zaleplon—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000584	0.000901	CcSEcCtD
Zaleplon—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000583	0.000899	CcSEcCtD
Zaleplon—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000582	0.000897	CcSEcCtD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00058	0.00585	CbGpPWpGaD
Zaleplon—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000579	0.000893	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000579	0.000893	CcSEcCtD
Zaleplon—GABRG2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000579	0.00584	CbGpPWpGaD
Zaleplon—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000579	0.000892	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000577	0.00089	CcSEcCtD
Zaleplon—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000574	0.000885	CcSEcCtD
Zaleplon—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000574	0.000885	CcSEcCtD
Zaleplon—Pain—Formoterol—chronic obstructive pulmonary disease	0.000574	0.000885	CcSEcCtD
Zaleplon—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000574	0.000885	CcSEcCtD
Zaleplon—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000573	0.000883	CcSEcCtD
Zaleplon—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000572	0.00578	CbGpPWpGaD
Zaleplon—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000572	0.000882	CcSEcCtD
Zaleplon—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000572	0.000882	CcSEcCtD
Zaleplon—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000571	0.00577	CbGpPWpGaD
Zaleplon—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000569	0.000877	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000568	0.000875	CcSEcCtD
Zaleplon—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000565	0.000871	CcSEcCtD
Zaleplon—GABRB2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000564	0.0057	CbGpPWpGaD
Zaleplon—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000563	0.000868	CcSEcCtD
Zaleplon—Pain—Montelukast—chronic obstructive pulmonary disease	0.000562	0.000866	CcSEcCtD
Zaleplon—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000559	0.000861	CcSEcCtD
Zaleplon—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000558	0.00086	CcSEcCtD
Zaleplon—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000558	0.000859	CcSEcCtD
Zaleplon—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000556	0.000857	CcSEcCtD
Zaleplon—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000556	0.000856	CcSEcCtD
Zaleplon—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000554	0.000854	CcSEcCtD
Zaleplon—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000553	0.000852	CcSEcCtD
Zaleplon—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000553	0.000852	CcSEcCtD
Zaleplon—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000552	0.000852	CcSEcCtD
Zaleplon—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000551	0.000849	CcSEcCtD
Zaleplon—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00055	0.000848	CcSEcCtD
Zaleplon—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00055	0.00555	CbGpPWpGaD
Zaleplon—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000549	0.000846	CcSEcCtD
Zaleplon—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000549	0.000846	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000547	0.000843	CcSEcCtD
Zaleplon—GABRB2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000545	0.0055	CbGpPWpGaD
Zaleplon—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000542	0.000835	CcSEcCtD
Zaleplon—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000542	0.000835	CcSEcCtD
Zaleplon—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000538	0.000829	CcSEcCtD
Zaleplon—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000537	0.000828	CcSEcCtD
Zaleplon—GABRA1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000535	0.0054	CbGpPWpGaD
Zaleplon—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000533	0.000822	CcSEcCtD
Zaleplon—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000533	0.000822	CcSEcCtD
Zaleplon—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000531	0.000818	CcSEcCtD
Zaleplon—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000531	0.000818	CcSEcCtD
Zaleplon—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000531	0.000818	CcSEcCtD
Zaleplon—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000531	0.000818	CcSEcCtD
Zaleplon—GABRA2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000529	0.00534	CbGpPWpGaD
Zaleplon—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000529	0.000815	CcSEcCtD
Zaleplon—GABRB3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000526	0.0053	CbGpPWpGaD
Zaleplon—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000525	0.000809	CcSEcCtD
Zaleplon—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000524	0.000808	CcSEcCtD
Zaleplon—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000524	0.000807	CcSEcCtD
Zaleplon—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000524	0.000807	CcSEcCtD
Zaleplon—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000522	0.000805	CcSEcCtD
Zaleplon—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000522	0.000805	CcSEcCtD
Zaleplon—CYP3A5—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000522	0.00527	CbGpPWpGaD
Zaleplon—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000521	0.000803	CcSEcCtD
Zaleplon—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00052	0.000801	CcSEcCtD
Zaleplon—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00052	0.000801	CcSEcCtD
Zaleplon—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000519	0.0008	CcSEcCtD
Zaleplon—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000518	0.000799	CcSEcCtD
Zaleplon—GABRG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000516	0.00521	CbGpPWpGaD
Zaleplon—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000513	0.00518	CbGpPWpGaD
Zaleplon—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000513	0.000791	CcSEcCtD
Zaleplon—GABRB2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000513	0.00517	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000511	0.00516	CbGpPWpGaD
Zaleplon—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00051	0.00515	CbGpPWpGaD
Zaleplon—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000509	0.000785	CcSEcCtD
Zaleplon—GABRB3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000508	0.00513	CbGpPWpGaD
Zaleplon—CYP3A7—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000506	0.00511	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000506	0.00511	CbGpPWpGaD
Zaleplon—CYP3A5—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000504	0.00508	CbGpPWpGaD
Zaleplon—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000503	0.000776	CcSEcCtD
Zaleplon—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000501	0.000772	CcSEcCtD
Zaleplon—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000501	0.000772	CcSEcCtD
Zaleplon—GABRG2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000499	0.00503	CbGpPWpGaD
Zaleplon—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000496	0.00501	CbGpPWpGaD
Zaleplon—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000494	0.000761	CcSEcCtD
Zaleplon—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000493	0.00076	CcSEcCtD
Zaleplon—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000493	0.000759	CcSEcCtD
Zaleplon—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000482	0.000742	CcSEcCtD
Zaleplon—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000482	0.000742	CcSEcCtD
Zaleplon—GABRA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000481	0.00485	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000478	0.00482	CbGpPWpGaD
Zaleplon—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000477	0.00481	CbGpPWpGaD
Zaleplon—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000475	0.000732	CcSEcCtD
Zaleplon—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000475	0.000732	CcSEcCtD
Zaleplon—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000474	0.000731	CcSEcCtD
Zaleplon—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000474	0.000731	CcSEcCtD
Zaleplon—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000472	0.000727	CcSEcCtD
Zaleplon—GABRG2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000469	0.00473	CbGpPWpGaD
Zaleplon—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000465	0.000717	CcSEcCtD
Zaleplon—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000455	0.000701	CcSEcCtD
Zaleplon—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000452	0.00456	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000451	0.00455	CbGpPWpGaD
Zaleplon—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000448	0.000691	CcSEcCtD
Zaleplon—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000444	0.000684	CcSEcCtD
Zaleplon—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000444	0.000684	CcSEcCtD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000438	0.00442	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000436	0.0044	CbGpPWpGaD
Zaleplon—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000435	0.00067	CcSEcCtD
Zaleplon—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000428	0.000659	CcSEcCtD
Zaleplon—Rash—Formoterol—chronic obstructive pulmonary disease	0.000423	0.000652	CcSEcCtD
Zaleplon—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000423	0.000652	CcSEcCtD
Zaleplon—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000423	0.000652	CcSEcCtD
Zaleplon—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000423	0.000652	CcSEcCtD
Zaleplon—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000423	0.000652	CcSEcCtD
Zaleplon—Headache—Formoterol—chronic obstructive pulmonary disease	0.00042	0.000648	CcSEcCtD
Zaleplon—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00042	0.000648	CcSEcCtD
Zaleplon—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.00042	0.000648	CcSEcCtD
Zaleplon—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000419	0.000646	CcSEcCtD
Zaleplon—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000419	0.000646	CcSEcCtD
Zaleplon—GABRB2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000418	0.00422	CbGpPWpGaD
Zaleplon—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000416	0.0042	CbGpPWpGaD
Zaleplon—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000415	0.00419	CbGpPWpGaD
Zaleplon—Rash—Montelukast—chronic obstructive pulmonary disease	0.000415	0.000639	CcSEcCtD
Zaleplon—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000414	0.000638	CcSEcCtD
Zaleplon—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000414	0.00418	CbGpPWpGaD
Zaleplon—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000413	0.000637	CcSEcCtD
Zaleplon—Depression—Prednisone—chronic obstructive pulmonary disease	0.000413	0.000636	CcSEcCtD
Zaleplon—Headache—Montelukast—chronic obstructive pulmonary disease	0.000412	0.000635	CcSEcCtD
Zaleplon—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00041	0.00414	CbGpPWpGaD
Zaleplon—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000407	0.000627	CcSEcCtD
Zaleplon—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000406	0.000626	CcSEcCtD
Zaleplon—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000402	0.000619	CcSEcCtD
Zaleplon—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.0004	0.000617	CcSEcCtD
Zaleplon—Rash—Salbutamol—chronic obstructive pulmonary disease	0.0004	0.000616	CcSEcCtD
Zaleplon—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000399	0.000616	CcSEcCtD
Zaleplon—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000399	0.00403	CbGpPWpGaD
Zaleplon—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000399	0.000615	CcSEcCtD
Zaleplon—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000399	0.000614	CcSEcCtD
Zaleplon—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000399	0.000614	CcSEcCtD
Zaleplon—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000397	0.000612	CcSEcCtD
Zaleplon—AOX1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000396	0.00399	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000395	0.00399	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000392	0.00395	CbGpPWpGaD
Zaleplon—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000391	0.000603	CcSEcCtD
Zaleplon—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00039	0.000602	CcSEcCtD
Zaleplon—GABRB3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000389	0.00393	CbGpPWpGaD
Zaleplon—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000385	0.000593	CcSEcCtD
Zaleplon—GABRG2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000382	0.00386	CbGpPWpGaD
Zaleplon—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000376	0.00058	CcSEcCtD
Zaleplon—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000375	0.000577	CcSEcCtD
Zaleplon—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000374	0.00377	CbGpPWpGaD
Zaleplon—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000371	0.00374	CbGpPWpGaD
Zaleplon—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00037	0.00057	CcSEcCtD
Zaleplon—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000366	0.00369	CbGpPWpGaD
Zaleplon—CYP3A7—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000366	0.00369	CbGpPWpGaD
Zaleplon—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000363	0.00056	CcSEcCtD
Zaleplon—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000363	0.00056	CcSEcCtD
Zaleplon—CYP3A7—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000362	0.00365	CbGpPWpGaD
Zaleplon—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000358	0.000551	CcSEcCtD
Zaleplon—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000355	0.000547	CcSEcCtD
Zaleplon—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000351	0.000542	CcSEcCtD
Zaleplon—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000347	0.000536	CcSEcCtD
Zaleplon—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000336	0.000518	CcSEcCtD
Zaleplon—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000334	0.00337	CbGpPWpGaD
Zaleplon—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000329	0.000507	CcSEcCtD
Zaleplon—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000329	0.000506	CcSEcCtD
Zaleplon—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000326	0.000503	CcSEcCtD
Zaleplon—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000326	0.000502	CcSEcCtD
Zaleplon—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000324	0.000499	CcSEcCtD
Zaleplon—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000311	0.000479	CcSEcCtD
Zaleplon—CYP3A7—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000304	0.00307	CbGpPWpGaD
Zaleplon—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000301	0.00303	CbGpPWpGaD
Zaleplon—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.0003	0.000463	CcSEcCtD
Zaleplon—CYP3A7—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.0003	0.00303	CbGpPWpGaD
Zaleplon—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.0003	0.000462	CcSEcCtD
Zaleplon—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000299	0.000461	CcSEcCtD
Zaleplon—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000297	0.000458	CcSEcCtD
Zaleplon—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000296	0.000456	CcSEcCtD
Zaleplon—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000294	0.00296	CbGpPWpGaD
Zaleplon—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000292	0.00045	CcSEcCtD
Zaleplon—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000291	0.000448	CcSEcCtD
Zaleplon—Syncope—Prednisone—chronic obstructive pulmonary disease	0.00029	0.000447	CcSEcCtD
Zaleplon—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000289	0.000445	CcSEcCtD
Zaleplon—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000284	0.000438	CcSEcCtD
Zaleplon—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000279	0.000431	CcSEcCtD
Zaleplon—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000276	0.000425	CcSEcCtD
Zaleplon—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000276	0.000425	CcSEcCtD
Zaleplon—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000275	0.000423	CcSEcCtD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000274	0.00277	CbGpPWpGaD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000274	0.000422	CcSEcCtD
Zaleplon—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000272	0.00042	CcSEcCtD
Zaleplon—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000264	0.00267	CbGpPWpGaD
Zaleplon—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000264	0.000407	CcSEcCtD
Zaleplon—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000264	0.000407	CcSEcCtD
Zaleplon—AOX1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000262	0.00265	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000261	0.00264	CbGpPWpGaD
Zaleplon—Shock—Prednisone—chronic obstructive pulmonary disease	0.00026	0.000401	CcSEcCtD
Zaleplon—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000259	0.000399	CcSEcCtD
Zaleplon—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000258	0.000397	CcSEcCtD
Zaleplon—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000257	0.000395	CcSEcCtD
Zaleplon—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000255	0.000394	CcSEcCtD
Zaleplon—AOX1—Metabolism—GC—chronic obstructive pulmonary disease	0.000255	0.00257	CbGpPWpGaD
Zaleplon—CYP3A7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000254	0.00256	CbGpPWpGaD
Zaleplon—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000252	0.000388	CcSEcCtD
Zaleplon—CYP3A7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00025	0.00252	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000243	0.00245	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000243	0.00245	CbGpPWpGaD
Zaleplon—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000241	0.000371	CcSEcCtD
Zaleplon—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00024	0.00037	CcSEcCtD
Zaleplon—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000239	0.000368	CcSEcCtD
Zaleplon—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000237	0.00239	CbGpPWpGaD
Zaleplon—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000237	0.000366	CcSEcCtD
Zaleplon—AOX1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000237	0.00239	CbGpPWpGaD
Zaleplon—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000234	0.00236	CbGpPWpGaD
Zaleplon—CYP3A7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000233	0.00235	CbGpPWpGaD
Zaleplon—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000233	0.000358	CcSEcCtD
Zaleplon—CYP3A7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.00023	0.00232	CbGpPWpGaD
Zaleplon—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00023	0.000354	CcSEcCtD
Zaleplon—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000229	0.000353	CcSEcCtD
Zaleplon—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000229	0.000353	CcSEcCtD
Zaleplon—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000228	0.000351	CcSEcCtD
Zaleplon—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000226	0.000348	CcSEcCtD
Zaleplon—CYP3A7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000221	0.00223	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00022	0.00222	CbGpPWpGaD
Zaleplon—CYP3A7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000218	0.0022	CbGpPWpGaD
Zaleplon—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000218	0.000335	CcSEcCtD
Zaleplon—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000217	0.00219	CbGpPWpGaD
Zaleplon—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000216	0.000333	CcSEcCtD
Zaleplon—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000216	0.000333	CcSEcCtD
Zaleplon—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000213	0.00215	CbGpPWpGaD
Zaleplon—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00021	0.000323	CcSEcCtD
Zaleplon—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000209	0.000322	CcSEcCtD
Zaleplon—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000209	0.000322	CcSEcCtD
Zaleplon—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000192	0.00194	CbGpPWpGaD
Zaleplon—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000292	CcSEcCtD
Zaleplon—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000187	0.000288	CcSEcCtD
Zaleplon—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000183	0.00185	CbGpPWpGaD
Zaleplon—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000181	0.00182	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000178	0.00179	CbGpPWpGaD
Zaleplon—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000269	CcSEcCtD
Zaleplon—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000172	0.00174	CbGpPWpGaD
Zaleplon—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00017	0.00172	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000168	0.0017	CbGpPWpGaD
Zaleplon—Rash—Prednisone—chronic obstructive pulmonary disease	0.000167	0.000257	CcSEcCtD
Zaleplon—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000256	CcSEcCtD
Zaleplon—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000166	0.00168	CbGpPWpGaD
Zaleplon—Headache—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000255	CcSEcCtD
Zaleplon—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.00016	0.00161	CbGpPWpGaD
Zaleplon—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000158	0.00159	CbGpPWpGaD
Zaleplon—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000242	CcSEcCtD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.00015	0.00151	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000144	0.00145	CbGpPWpGaD
Zaleplon—AOX1—Disease—HDAC2—chronic obstructive pulmonary disease	0.00014	0.00141	CbGpPWpGaD
Zaleplon—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00014	0.00141	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000139	0.00141	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000138	0.00139	CbGpPWpGaD
Zaleplon—AOX1—Disease—KL—chronic obstructive pulmonary disease	0.00013	0.00131	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	0.000128	0.0013	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000126	0.00127	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000124	0.00125	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000123	0.00124	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000122	0.00123	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000122	0.00123	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000118	0.00119	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000116	0.00118	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000116	0.00117	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000116	0.00117	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	0.000115	0.00116	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000114	0.00115	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000106	0.00107	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000104	0.00105	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000102	0.00103	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000101	0.00102	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.93e-05	0.001	CbGpPWpGaD
Zaleplon—AOX1—Disease—ERBB3—chronic obstructive pulmonary disease	9.75e-05	0.000983	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.66e-05	0.000975	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.53e-05	0.000961	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.88e-05	0.000896	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.52e-05	0.00086	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.51e-05	0.000859	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	8.42e-05	0.000849	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.41e-05	0.000849	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.41e-05	0.000848	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	8.28e-05	0.000835	CbGpPWpGaD
Zaleplon—AOX1—Disease—NOS2—chronic obstructive pulmonary disease	8.13e-05	0.00082	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.83e-05	0.00079	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.72e-05	0.000779	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.7e-05	0.000777	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.46e-05	0.000753	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.42e-05	0.000749	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.32e-05	0.000739	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.99e-05	0.000706	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.95e-05	0.000701	CbGpPWpGaD
Zaleplon—AOX1—Disease—SERPINE1—chronic obstructive pulmonary disease	6.84e-05	0.00069	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.82e-05	0.000688	CbGpPWpGaD
Zaleplon—AOX1—Disease—NOS3—chronic obstructive pulmonary disease	6.53e-05	0.000659	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.26e-05	0.000631	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	6.19e-05	0.000624	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	5.97e-05	0.000603	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.96e-05	0.000602	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ALB—chronic obstructive pulmonary disease	5.72e-05	0.000577	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	5.64e-05	0.00057	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.47e-05	0.000552	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.2e-05	0.000525	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.52e-05	0.000456	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	4.47e-05	0.000451	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.34e-05	0.000438	CbGpPWpGaD
Zaleplon—AOX1—Disease—TGFB1—chronic obstructive pulmonary disease	4.32e-05	0.000436	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.28e-05	0.000432	CbGpPWpGaD
Zaleplon—AOX1—Disease—EGFR—chronic obstructive pulmonary disease	4.24e-05	0.000427	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	4.08e-05	0.000412	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.99e-05	0.000402	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.96e-05	0.000399	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	3.85e-05	0.000388	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.78e-05	0.000381	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.76e-05	0.000379	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.58e-05	0.000361	CbGpPWpGaD
Zaleplon—AOX1—Disease—IL6—chronic obstructive pulmonary disease	3.25e-05	0.000328	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.14e-05	0.000316	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.09e-05	0.000312	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.88e-05	0.000291	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.73e-05	0.000276	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	2.57e-05	0.000259	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	2.46e-05	0.000248	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.1e-05	0.000212	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.08e-05	0.00021	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.9e-05	0.000191	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	1.86e-05	0.000187	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	1.78e-05	0.000179	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.75e-05	0.000176	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.46e-05	0.000147	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.44e-05	0.000145	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.34e-05	0.000135	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.27e-05	0.000128	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	8.63e-06	8.71e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	8.26e-06	8.33e-05	CbGpPWpGaD
